SCHEMBL6550929

SCHEMBL6550929

COc1ccc(C2(c3ccccc3)CC(=O)c3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.46
OPRM1 P35372 2/20 0.45
OPRL1 P41146 2/20 0.45
SLC6A3 Q01959 2/20 0.42
PGR P06401 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
BACE1 P56817 1/20 0.40
BACE2 Q9Y5Z0 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
MAOA P21397 1/20 0.40
PTGS2 P35354 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181563 0.86 CFTR (0.48) MAPTNPC1RAB9AKMT2ATP53
SCHEMBL30074263 0.86 CFTR (0.48) MAPTNPC1RAB9AKMT2ATP53
SCHEMBL6550908 0.80 CFTR (0.41) MAPTNPC1KMT2AOPRM1TP53
SCHEMBL6552460 0.80 ESR1 (0.51) MAPTKMT2ASLC6A3SLC6A2SLC6A4
SCHEMBL28606394 0.80 MDM2 (0.40) MAPTKMT2AOPRM1PGRTP53
Propionic Acid SCHEMBL4796324 0.78 PKM (0.41) MAPTRAB9AKMT2AOPRM1TP53
SCHEMBL28609498 0.76 PGR (0.38) MAPTKMT2APGRTP53SMN1; SMN2
SCHEMBL14462993 0.73 S100A4 (0.42) KMT2ASMN1; SMN2MEN1ALDH1A1TDP1
SCHEMBL28610336 0.73 NPSR1 (0.57) MAPTKMT2AOPRM1OPRL1PGR
SCHEMBL20414407 0.73 KMT2A (0.53) MAPTNPC1RAB9AKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1047411-B1 SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS AND ANALOGUES THEREOF USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION HARVARD COLLEGE (US) 2004-02-11 EP disclosed